Featured Articles

  1. Amgen's Ian Thompson On Leadership And A Global Mindset 4/8/2025

    Ian Thompson, SVP and general manager of U.S. business operations at Amgen, shares his leadership philosophy, what he's learned from working in global markets, and key pipeline highlights.

  2. How AI Redefines The Functional Service Provider Opportunity In Medical Affairs 4/7/2025

    Medical affairs can no longer afford to operate within legacy structures. Enter AI-enabled functional service provider (FSP) models that offer operational relief.

  3. Biopharma Should Focus On Product Iteration Over Product Launches 4/4/2025

    Building iteration into the product commercialization process can help life sciences companies avoid many of the missteps that slow down adoption and stall growth, explains Jessica Meng.

  4. Breaking Barriers: From Gendered Perceptions To Inclusive Leadership 4/2/2025

    Leadership in pharma means questioning assumptions, amplifying diverse voices, and creating environments where authenticity and empathy are recognized as strengths, explains Laryssa Wozniak.

  5. Risk Management Planning: Be Prepared When Disaster Strikes 4/1/2025

    Few life sciences companies are ready for a disaster, particularly a cyber one. Key factors include an integrated approach to cyber preparedness and risk planning, a dedicated team, and more.

  6. Companies To Watch: Imunon 3/31/2025

    Imunon aims to shake up the standard of care in the frontline treatment of advanced ovarian cancer.

  7. Navigating AI's Impact On Life Sciences And Patent Law 3/26/2025

    AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and sufficiency of disclosure, explains patent attorney Noah K. Tilton.

  8. How To Get Ready For The Talent Migration Between Pharma And Biotech 3/25/2025

    A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in Big Pharma and biotech culture and expectations to be successful.

  9. Resetting The Immune System For Lasting Remission 3/19/2025

    Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and inflammatory conditions, using novel targets and improved modalities.

  10. 3D Screen Printing: Enabling A New Generation Of Complex Formulations 3/17/2025

    Screen-Printed Innovative Drug Technology can produce oral, transdermal, and implantable dosage forms while ensuring heterogeneous distribution of active ingredients.